Single agent chemotherapy with weekly docetaxel vs combination chemotherapy in second-line treatment of advanced non small cell lung cancer
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Capecitabine; Docetaxel; Gemcitabine; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms DISTAL-2
- 01 Feb 2009 Primary endpoint 'overall Survival duration' has not been met.
- 01 Feb 2009 Results reported in Lung Cancer.
- 26 May 2008 Results presented at ASCO 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History